FDA Inspection 1117958 — Alexandra Chalastanis PHD
The FDA completed an inspection of Alexandra Chalastanis PHD on January 17, 2020 in Meyrin. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 17, 2020
- Fiscal Year
- 2020
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Meyrin (Switzerland)
Additional Details
Clinical Investigator (CI)